Cytek Biosciences Reports Third Quarter 2025 Financial Results
(NASDAQ:CTKB), FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Cytek(R) Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights Total revenue for the third quarter of 2025 was $52.3 million, representing a 2% increase compared to […]